Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients - PubMed (original) (raw)
Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients
R Kornowski et al. Am J Cardiol. 1998.
Abstract
This study assessed the impact of diabetes mellitus on atherosclerotic lesion formation. Seventy insulin-treated diabetics, 150 non-insulin-treated diabetics, and 607 nondiabetics with chronic anginal syndromes and de novo native coronary stenoses were studied using (1) angiography, and (2) intravascular ultrasound (reference and lesion arterial, lumen, and plaque areas; area stenosis [reference-lesion/reference lumen area]; remodeling index [reference-lesion lumen area/lesion-reference plaque area]; and slope of the regression line relating lumen area to plaque burden [plaque/arterial area]). Despite being diabetic for longer and having similar lumen compromise, insulin-treated patients had (1) less reference plaque (8.3 +/- 3.4 vs 10.5 +/- 4.5 mm2, p = 0.0015), (2) less stenosis plaque (13.0 +/- 4.9 vs 16.9 mm2, p <0.0001), (3) smaller reference arterial areas (17.1 +/- 5.4 vs 19.7 +/- 6.2 mm2, p = 0.0063), and (4) smaller stenosis arterial areas (15.3 +/- 4.9 vs 19.5 +/- 6.5 mm2, p <0.0001) than non-insulin-treated diabetics. With use of multivariate linear regression analysis, insulin use was an independent (and negative) predictor of reference plaque and arterial areas (p = 0.0308 and p = 0.0179) and stenosis plaque and arterial areas (p = 0.0117 and p = 0.0066). This was also true when normalized for body surface area. The remodeling index showed that insulin treatment resulted in an exaggerated impact of plaque accumulation on lumen compromise. This was confirmed by the slope of the regression line relating lumen area to plaque burden. Patients with a longer duration of diabetes who were treated with insulin for > or = 1 year had (paradoxically) less reference segment and stenosis plaque accumulation. Possible explanations include impaired adaptive remodeling and/or arterial (and plaque) shrinkage.
Similar articles
- Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients.
Jensen LO, Thayssen P, Mintz GS, Maeng M, Junker A, Galloe A, Christiansen EH, Hoffmann SK, Pedersen KE, Hansen HS, Hansen KN. Jensen LO, et al. Eur Heart J. 2007 Jul;28(14):1759-64. doi: 10.1093/eurheartj/ehm175. Epub 2007 May 31. Eur Heart J. 2007. PMID: 17540850 - Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts.
Hong MK, Mintz GS, Hong MK, Abizaid AS, Pichard AD, Satler LF, Kent KM, Leon MB. Hong MK, et al. Am J Cardiol. 1999 Nov 1;84(9):992-8. doi: 10.1016/s0002-9149(99)00486-5. Am J Cardiol. 1999. PMID: 10569652 - Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.
Schukro C, Syeda B, Yahya N, Gessl A, Holy EW, Pichler P, Derntl M, Glogar D. Schukro C, et al. J Diabetes Complications. 2007 Nov-Dec;21(6):381-6. doi: 10.1016/j.jdiacomp.2007.06.007. J Diabetes Complications. 2007. PMID: 17967711 Clinical Trial. - [New methods of coronary imaging II. Intracoronary ultrasonography in clinical practice].
Sgura FA, Di Mario C. Sgura FA, et al. Ital Heart J Suppl. 2001 Jun;2(6):579-92. Ital Heart J Suppl. 2001. PMID: 11460831 Review. Italian. - The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches.
Tousoulis D, Kampoli AM, Papageorgiou N, Papaoikonomou S, Antoniades C, Stefanadis C. Tousoulis D, et al. Curr Pharm Des. 2009;15(17):2037-48. doi: 10.2174/138161209788453185. Curr Pharm Des. 2009. PMID: 19519440 Review.
Cited by
- Assessment of prevalence and risk factors of isolated coronary artery ectasia: A 5-year double-center retrospective study in Yazd, Iran.
Nough H, Moradi F, Varasteravan HR, Afkhami L, Azimizadeh M, Mohammadi H, Shafiee M, Emami M, Hossein Sartipzade N, Safi Dahaj F, Nough A. Nough H, et al. Caspian J Intern Med. 2024 Spring;15(2):244-250. doi: 10.22088/cjim.15.2.244. Caspian J Intern Med. 2024. PMID: 38807718 Free PMC article. - Effect of type 2 diabetes on coronary artery ectasia: smaller lesion diameter and shorter lesion length but similar adverse cardiovascular events.
Cai Z, Li L, Wang H, Yuan S, Yin D, Song W, Dou K. Cai Z, et al. Cardiovasc Diabetol. 2022 Jan 19;21(1):9. doi: 10.1186/s12933-022-01444-5. Cardiovasc Diabetol. 2022. PMID: 35045850 Free PMC article. - Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study.
Ke JF, Wang JW, Zhang ZH, Chen MY, Lu JX, Li LX. Ke JF, et al. Front Cardiovasc Med. 2021 Feb 1;8:599545. doi: 10.3389/fcvm.2021.599545. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33598483 Free PMC article. - The Relationship between CAR and CAE: Association of C-Reactive Protein to Albumin Ratio in Patients with Isolated Coronary Artery Ectasia.
Castro I, Fontana Filho HA. Castro I, et al. Arq Bras Cardiol. 2021 Jan;116(1):55. doi: 10.36660/abc.20200580. Arq Bras Cardiol. 2021. PMID: 33566964 Free PMC article. English, Portuguese. No abstract available. - Is Lipoprotein (a) a Risk Factor for Coronary Artery Ectasia?
Al-Makhamreh HK, Shaban AE, AlHaddadin SS, AlSharif AA, Ghalayni RA, Daoud LF, Alshraideh BM. Al-Makhamreh HK, et al. Cardiol Res. 2020 Feb;11(1):50-55. doi: 10.14740/cr992. Epub 2020 Jan 26. Cardiol Res. 2020. PMID: 32095196 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical